Emergent BioSolutions to Participate in Investor Conferences
KeyBanc Life Sciences & MedTech Investor Forum March 22, 2022
Company fireside chat scheduled for1:30 pm eastern
https://wsw.com/webcast/key21/ebs/1521976
BofA Securities 2022 Healthcare ConferenceMay 10, 2022
Presentation scheduled for12:00 pm eastern
- Goldman Sachs 7th Annual
Leveraged Finance and Credit Conference May 11 to 13, 2022
Presentation date and time will be updated on the Emergent website as the information becomes available.
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.
About
At Emergent, our mission is to protect and enhance life. For over 20 years, we’ve been at work defending people from things we hope will never happen—so we are prepared, just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our website and follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:
Vice President, Investor Relations
240-631-3280
burrowsr@ebsi.com
Media Contact:
Senior Director, Media Relations
mediarelations@ebsi.com
Source: Emergent BioSolutions